Novo Nordisk, a leading global healthcare company, has announced the signing of a MoU with Lifera, a biopharmaceutical ...

Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...

The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

All of these weight loss medications fall under the pharmaceutical umbrella of Glucagon-like Peptide 1 (GLP-1) receptor ...